An oncolytic herpes simplex virus armed with IL-12 for treatment of preclinical glioblastoma.
Saved in:
| Title: | An oncolytic herpes simplex virus armed with IL-12 for treatment of preclinical glioblastoma. |
|---|---|
| Authors: | Jackson JW; Department of Medicine, University of Tennessee Graduate School of Medicine, Knoxville, TN 37920, USA., Hall BL; Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, PA 15219, USA., Sneiderman C; Department of Neurological Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA 15219, USA., Webb A; Department of Biostatistics, The Ohio State University, Columbus, OH 43210, USA., Hancock TJ; Department of Medicine, University of Tennessee Graduate School of Medicine, Knoxville, TN 37920, USA., Vlasyuk M; Department of Medicine, University of Tennessee Graduate School of Medicine, Knoxville, TN 37920, USA., Bailey L; Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, PA 15219, USA., Xiaokui M; Department of Biostatistics, The Ohio State University, Columbus, OH 43210, USA., Solomon IH; Division of Neuropathology, Department of Pathology, Brigham and Women's Hospital, Boston, MA 02115, USA., Ligon K; Division of Neuropathology, Department of Pathology, Brigham and Women's Hospital, Boston, MA 02115, USA., Goins WF; Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, PA 15219, USA., Kohanbash G; Department of Neurological Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA 15219, USA., Chiocca EA; Harvey W. Cushing Neuro-oncology Laboratories (HCNL), Department of Neurosurgery, Harvard Medical School and Brigham and Women's Hospital, Boston, MA 02115, USA., Glorioso JC; Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, PA 15219, USA. |
| Source: | Molecular therapy. Oncology [Mol Ther Oncol] 2025 Aug 06; Vol. 33 (3), pp. 201030. Date of Electronic Publication: 2025 Aug 06 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Inc Country of Publication: United States NLM ID: 9918752083706676 Publication Model: eCollection Cited Medium: Print ISSN: 2950-3299 (Print) Linking ISSN: 29503299 NLM ISO Abbreviation: Mol Ther Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
